690 results on '"Michaux, L."'
Search Results
2. Nouveautés dans la prise en charge des pneumopathies d’hypersensibilité
3. Development of CuAlNi Shape Memory Alloy Structures Using Cold Spray Deposition Technique with Laser Remelting
4. Hot methane line lists for exoplanet and brown dwarf atmospheres
5. RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
6. Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
7. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
8. 60 Comprehensive genome-wide analysis of non-invasive test data allows accurate cancer prediction: a retrospective analysis of over 85.000 pregnancies
9. Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia
10. FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib
11. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
12. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL
13. Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine
14. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation
15. Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
16. miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2
17. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast
18. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome–acute myeloid leukemia actually differ?
19. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations
20. Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL
21. An Unusual Course of Donor-Transmitted Angiosarcoma after Lung Transplantation
22. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome
23. Translocation t(2;3)(p15–23;q26–27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features
24. High incidence of complications after 2-chloro-2’-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies
25. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
26. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)
27. Genetics of Chronic Lymphocytic Leukemia: Practical Aspects and Prognostic Significance
28. Concurrent spinal cord and vertebral bone marrow radionecrosis 8 years after therapeutic irradiation
29. Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression
30. Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage
31. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes
32. Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma
33. The value of interphase fluorescence in situ hybridization for the detection of translocation t(12;21) in childhood acute lymphoblastic leukemia
34. ‘Wait a Minute, Mr Postman’: On Universal Service, the Postal Services Directive and the SGEI Framework · Joined Cases C-431/19 P and C-432/19 P Inpost · Annotation by Joris Gruyters and Lennard Michaux
35. MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients
36. Magnetic resonance imaging of the bone marrow in hematological malignancies
37. Trisomy 3q11-q29 is recurrently observed in B-cell non-Hodgkin's lymphomas associated with cold agglutinin syndrome
38. Rare IgH/14q32 Translocations in Multiple Myeloma: B390
39. Multiple Myeloma in Black Africans: Does It Behave Differently?: A626
40. The t(14;20)(q32;q12): A Rare Cytogenetic Change in Multiple Myeloma (MM) Associated with Poor Outcome: A182
41. Het ondernemingsbegrip in het mededingingsrecht, het marktpraktijkenrecht en het consumentenrecht
42. A rare cause of high liver stiffness
43. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
44. Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib
45. A rare cause of high liver stiffness
46. miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2
47. Het ondernemingsbegrip in het mededingingsrecht, het marktpraktijkenrecht en het consumentenrecht
48. Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
49. Referral bias in allogeneic haematopoietic stem cell transplantation
50. Lymphomes folliculaires
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.